Target intelligence / Profile preview

Neuropeptide (NP)

Target
NP
Molecular classification
Peptide, Signaling molecule, Neuromodulator, Neurohormone
01

Overview

Neuropeptides are a vast and diverse class of small signaling molecules, typically ranging from 3 to 40 amino acids, that are synthesized and released by neurons to modulate various physiological and behavioral processes. They act primarily as ligands for G protein-coupled receptors (GPCRs), where they influence critical functions such as appetite, sleep-wake cycles, pain perception, and the stress response. Unlike classical small-molecule neurotransmitters, neuropeptides often exhibit a slower onset and more prolonged duration of action, frequently functioning as neuromodulators that fine-tune the activity of neural circuits rather than mediating rapid synaptic transmission. In clinical medicine, the neuropeptide signaling systems are major targets for addressing conditions ranging from metabolic disorders and chronic pain to neurological and psychiatric ailments. However, the term "Neuropeptide" refers to a broad functional category containing hundreds of distinct molecules—such as Substance P, Oxytocin, and Neuropeptide Y—rather than a single specific protein target. Key therapeutic challenges in this space include the high susceptibility of peptides to enzymatic degradation and the difficulty of delivering large, polar molecules across the blood-brain barrier.

Other names
Neurotransmitter peptidePeptidergic signaling moleculeNeuromodulatory peptideNeuroactive peptide
02

Mechanism of action

Modulation of G protein-coupled receptors (GPCRs) as agonists, antagonists, or allosteric modulators; some therapeutic strategies also utilize monoclonal antibodies to sequester the neuropeptide ligands directly.

03

Biological functions

NeuromodulationAppetite and energy homeostasis regulationPain perception and signalingSleep-wake cycle regulationStress response and anxiety modulationSocial behavior and bondingCircadian rhythm modulation
04

Disease associations

ObesityChronic painInsomniaAnxiety and DepressionMigraineNeurodegenerative diseaseNausea and VomitingAddiction
05

Safety considerations

Low blood-brain barrier (BBB) permeabilityRapid proteolytic degradation by peptidasesBroad off-target effects due to widespread receptor distributionPotential for tachyphylaxis or tolerance with chronic use
06

Interacting drugs

Aprepitant

7 more in the full profile.

07

Biomarkers

Cerebrospinal fluid (CSF) Orexin/Hypocretin-1 levelsPlasma Calcitonin Gene-Related Peptide (CGRP) levelsProcalcitonin (sepsis biomarker)Spexin (acute pancreatitis biomarker)Neuropeptide Y (NPY) levels

Beyond the preview

Go deeper on Neuropeptide (NP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuropeptide (NP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call